After nearly three years, the COVID-19 research collaboration between Vir Biotechnology and GSK has largely come to an end, as Vir announced Monday it would be going it alone or with other partners in this space.
https://www.pharmalive.com/wp-content/uploads/2023/02/BioSpaceGSK2-1-2023.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2023-02-14 11:37:472023-02-14 11:37:47GSK abandons COVID-19 collaboration with Vir